Seeking Alpha Author Dr. Bhavneesh Sharma joins Cheddar to discuss the newest breakthrough in obesity treatment. He's been following Rhythm Pharmaceuticals, Inc. a biopharma company developing therapeutics for rare genetic deficiencies that result in life-threatening metabolic disorders. Rhythm is advancing clinical research programs evaluating setmelanotide as a first-in-class treatment for a number of rare genetic forms of obesity caused by deficiencies in the MC4, a key biological pathway in humans that regulates weight by increasing energy expenditure and reducing appetite. Dr. Sharma talks about just how rare these genetic forms are and how much this treatment is needed for patients.